RFA-CK-26-104: Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2026.
Centers for Disease Control and Prevention - ERA offered grants of up to $1.0 million (at least $500,000) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expected to make about 2 awards worth $10.0 million in total. Applications closed on July 6, 2026.
From the official notice on Grants.gov, last changed June 4, 2026. Checked November 7, 2026.
- Award ceiling$1.0 million
- Award floor$500,000
- Total funding$10.0 million
- Expected awards2
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 4, 2026 |
|---|---|
| Deadline | July 6, 2026 |
| Archived by Grants.gov | August 5, 2026 |
Who can apply
This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes and businesses.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Foreign Organizations: a Foreign Organization is a public or private organization, whether non-profit or for-profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of the project staff or place of performance.
Is this a realistic fit?
- Past Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention awards averaged $1.7 million; this notice allows up to $1.0 million per award.
- Most of the program's money (51% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this notice of funding opportunity (NOFO) is to expand the network of institutes working with CDC to help eliminate or control non-malaria parasitic threats and neglected tropical diseases (NTDs). This NOFO will focus on threats and diseases that may affect Americans at home or abroad or whose elimination or control would serve other U.S. priorities. This program will also support research that will provide tools and information to improve NTD and parasitic disease program activities. The program will also integrate evaluation and surveillance activities for multiple NTDs and other parasitic diseases.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before
From fiscal 2021 to 2025, Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention (93.326) awarded $345 million across 205 grant awards, an average of $1.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Washington State University | Washington | 2 | $23.2 million |
| Association of Public Health Laboratories, Inc. (the) | Maryland | 2 | $19.6 million |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 2 | $13.3 million | |
| Liverpool School of Tropical Medicine | 1 | $10.6 million | |
| California Department of Public Health | California | 1 | $10.3 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFA-CK-26-104 still open?
No. It closed on July 6, 2026.
Who can apply for Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad?
Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes and businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Eliminating Parasitic and Neglected Tropical Disease Threats to the United States - Program Support and Research to Reduce Threats to Americans at Home and Abroad?
Closed July 6, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each. About $10.0 million in total across about 2 awards.
Who has won Strengthening Public Health through Surveillance, Epidemiologic Research, Disease Detection and Prevention grants before?
The largest recipients over five fiscal years were Washington State University, Association of Public Health Laboratories, Inc. (the), International Centre for Diarrhoeal Disease Research, Bangladesh. The program made 205 awards worth $345 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)